Multiple sclerosis.
Study Design
- Study Type
- Review
- Population
- Patients with multiple sclerosis
- Intervention
- Multiple sclerosis. None
- Comparator
- None
- Primary Outcome
- Multiple sclerosis management overview
- Effect Direction
- Neutral
- Risk of Bias
- Unclear
Abstract
Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system. Common manifestations include paresthesias, diplopia, loss of vision, numbness or weakness of the limbs, bowel or bladder dysfunction, spasticity, ataxia, fatigue, and mental changes. Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapsing. The cause of MS is unknown, although it appears to be an autoimmune disease. Much of what is known about MS has been learned from an animal model of the disease, experimental allergic encephalomyelitis.
TL;DR
Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapse, which is an autoimmune disease.
Used In Evidence Reviews
Similar Papers
Archives of internal medicine · 2009
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.
Journal of autoimmunity · 2019
Systemic lupus erythematosus: Diagnosis and clinical management.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2011
Vitamin D and the immune system.
Archives of disease in childhood · 2021
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.
Gastroenterology · 2010
Primary prevention of colorectal cancer.
Journal of cachexia, sarcopenia and muscle · 2020